Funda Meric-Bernstam, MD, co-chair of the 2021 Cholangiocarcinoma Foundation Annual Conference, gives her insight on immunotherapies in cholangiocarcinoma.
Funda Meric-Bernstam, MD, chair of the Department of Investigational Cancer Therapeutics and medical director of the Institute for Personalized Cancer Therapy at The University of Texas MD Anderson Cancer Center, and co-chair of the 2021 Cholangiocarcinoma Foundation Annual Conference, gives her insight on immunotherapies in cholangiocarcinoma.
Transcript
One session focuses on immuno-oncology, a growing class of therapies for cholangiocarcinoma. What are some recent advances you think may come up in this discussion?
We're so excited about immunotherapy in general, and of course immunotherapy has really revolutionized the care of multiple diseases. These are diseases of what we call "hot" diseases, where we think that the tumor is more immunogenic, which means the tumor has features that the body is likely to perceive as not normal and more likely to mount an immune response to it with just a little bit of help. Chelangiocarcinoma is not one of those diseases where we think is readily going to be benefit from immunotherapy across the board in all patients. Thus, we're really trying to figure out how we identify the patients that would benefit from just checkpoint inhibitors. That is some patients, but all in all, not most patients. But also, there's many different combination therapies in development, and which one of those combination therapies are likely to be fruitful? And how do we determine that? What is the path forward, and what are the logical combinations should we be exploring, and what are the new technologies being developed in the space? [We're] looking at different cellular therapy strategies, looking at novel bispecific strategies, looking at strategies such as vaccines. I think we're going to be covering a variety of different perspectives, so again, that should be very interesting session.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More